顶部logo
顶部logo
more_1

home

ホーム > レポート一覧 > グローバルMHCテトラマー市場規模、主要企業シェア、ランキング分析レポート【2026年版】

グローバルMHCテトラマー市場規模、主要企業シェア、ランキング分析レポート【2026年版】

Major Histocompatibility Complex (MHC) Tetramer - Global Top Players Market Share and Ranking 2026
  • レポートID：
    56915
  • 発表時期：
    2026-01-07
  • レポート形式：
    PDF
  • 産業カテゴリー：
  • レポート言語：
    英語、日本語
  • ページ数：
    100
  • 発行会社（調査会社）：
    YHResearch
title

言語とエディションの価格

  • 英語版
  • 日本語版
  • 英語と日本語版

個人版詳細

マルチユーザー版詳細

企業版詳細

  • 英語版
  • 日本語版
  • 英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.40円。

※米ドル表示価格+10％消費税。

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

title

レポートの概要

本報告書は、世界のMHCテトラマー市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。総販売数量、売上高、価格動向に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点からMHCテトラマー市場を分析し、需要構造と成長特性を明確化します。
MHCテトラマー市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における販売数量および売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、MHCテトラマーに関する的確な意思決定を行うための実践的なインサイトを提供します。
 主要MHCテトラマー市場の統計
2025年世界市場規模：13.77百万米ドル
2026年世界市場規模：14.78百万米ドル
2032年予測市場規模：23.01百万米ドル
2026–2032年予測期間CAGR：7.7%
本レポートはMHCテトラマー市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。 
【市場セグメンテーション】
主要企業・競争環境
MHCテトラマー市場の主要企業には以下が含まれます：
MBL Life Science
ProImmune
BioLegend
KACTUS
Creative Biolabs
immunAware
HELIXGEN
ACROBiosystems 

製品別
MHC-I
MHC-II 

アプリケーション別
Cancer research
Virus research
Bacteria research
Other 

レポート対象地域
北米：アメリカ、カナダ、その他
アジア太平洋：中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ：メキシコ、ブラジル、その他
中東・アフリカ：トルコ、サウジアラビア、UAE、その他

レポート構成（章別概要）
第1章｜市場概要と成長展望
MHCテトラマー市場の全体像を整理し、市場規模、売上予測、価格推移を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章｜主要企業の競争分析
MHCテトラマー市場における主要プレイヤー（トップ5社・トップ10社）を対象に、売上高、製造拠点、製品構成、価格戦略、販売量、市場シェアを多面的に分析し、競争構造を明確化します
第3章｜製品カテゴリ別市場動向
製品タイプ別にMHCテトラマー市場を分類し、売上高、市場シェア、販売量、価格動向を分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章｜用途別市場動向
用途別にMHCテトラマー市場規模、売上高、市場シェア、販売量、価格推移を整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章｜地域別市場分析
地域別の市場成長率、販売量、売上高を詳細に分析し、MHCテトラマー市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します
第6章｜国別市場動向
主要国・地域ごとに、MHCテトラマー市場の販売量、売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章｜主要企業プロファイル
MHCテトラマー市場を牽引する主要企業について、売上高、販売量、価格動向、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章｜バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章｜調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章｜付録（調査手法・データソース）
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します

本レポートの要点と洞察
 MHCテトラマー市場の全体像と成長見通し
MHCテトラマー市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境がMHCテトラマー市場に与える影響を分析いたします
 市場環境の構成要素とマクロトレンド
MHCテトラマー産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略や価格形成に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します
 競争構造と主要企業の動向分析
MHCテトラマー市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します
 競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点からMHCテトラマー市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします
 成長要因・課題・リスクの分析
MHCテトラマー市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します
 将来トレンドと市場展望
MHCテトラマー市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします
title

Description

According to YH Research, the global market for Major Histocompatibility Complex (MHC) Tetramer should grow from US$ 13.77 million in 2025 to US$ 23.01 million by 2032, with a CAGR of 7.7% for the period of 2026-2032.

An MHC tetramer is a laboratory tool used to study antigen-specific T cells. It consists of four major histocompatibility complex (MHC) molecules bound to a specific peptide and labeled with a fluorescent tag. These tetramers can bind to T cell receptors (TCRs) on the surface of T cells that recognize the specific peptide-MHC complex. By using flow cytometry, researchers can identify and quantify antigen-specific T cells, making MHC tetramers a valuable tool for immunological studies, including vaccine development, cancer immunotherapy, and infectious disease research.
In 2023, North America accounted for the largest sales share of the MHC tetramer market. The region is characterized by a large number of pharmaceutical R&D service providers. Meanwhile, Asia Pacific is expected to witness the highest CAGR during the forecast period.

The major global companies of Major Histocompatibility Complex (MHC) Tetramer include MBL Life Science, ProImmune, BioLegend, KACTUS, Creative Biolabs, immunAware, HELIXGEN, ACROBiosystems and etc. In 2023, the world's top three vendors accounted for approximately 56.50% of the revenue.

In terms of application, the continued research demand for cancer immunotherapy and adoptive T cell therapy and immune responses to emerging and re-emerging viral infectious diseases such as COVID-19, HIV and influenza is the main reason driving the MHC tetramer market. In 2023, MHC tetramers for cancer research accounted for approximately 48.00% of the market.

Currently, the MHC tetramer market mainly consists of two types: MHC-I and MHC-II. MHC-I is mainly used for research on cancer, viruses, bacteria, etc., and MHC-II is mainly used for research on viruses, bacteria, allergens, etc. In 2023, the sales of MHC-I and MHC-II will be US$6.63 million and US$4.29 million, respectively.

This report studies and analyses global Major Histocompatibility Complex (MHC) Tetramer status and future trends, to help determine the Major Histocompatibility Complex (MHC) Tetramer market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Major Histocompatibility Complex (MHC) Tetramer, and provides market size (US$ million) and Year-over-Year growth, considering 2025 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Major Histocompatibility Complex (MHC) Tetramer market size, history data 2021-2025, and forecast data 2026 -2032, (US$ million)
(2) Global Major Histocompatibility Complex (MHC) Tetramer by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(3) Japan Major Histocompatibility Complex (MHC) Tetramer by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(4) Global Major Histocompatibility Complex (MHC) Tetramer key consuming regions, consumption value and demand structure
(5) Major Histocompatibility Complex (MHC) Tetramer industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    MBL Life Science
    ProImmune
    BioLegend
    KACTUS
    Creative Biolabs
    immunAware
    HELIXGEN
    ACROBiosystems

Market segment by Type, covers
    MHC-I
    MHC-II

Market segment by Application, can be divided into
    Cancer research
    Virus research
    Bacteria research
    Other

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Major Histocompatibility Complex (MHC) Tetramer product scope, global consumption value, Japan consumption value, development opportunities, challenges, trends, and policies
Chapter 2: Global Major Histocompatibility Complex (MHC) Tetramer market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 3: Japan Major Histocompatibility Complex (MHC) Tetramer market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 4: Major Histocompatibility Complex (MHC) Tetramer industry chain, upstream, medium-stream, and downstream
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2021-2032
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2021-2032
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin
Chapter 10: Conclusions
title

Table of Contents

1 Market Overview
    1.1 Major Histocompatibility Complex (MHC) Tetramer Definition
    1.2 Global Major Histocompatibility Complex (MHC) Tetramer Market Size and Forecast
    1.3 Japan Major Histocompatibility Complex (MHC) Tetramer Market Size and Forecast
    1.4 Share of Japan Major Histocompatibility Complex (MHC) Tetramer Market with Respect to the Global Market
    1.5 Major Histocompatibility Complex (MHC) Tetramer Market Size: Japan VS Global Growth Rate, 2021-2032
    1.6 Major Histocompatibility Complex (MHC) Tetramer Market Dynamics
        1.6.1 Major Histocompatibility Complex (MHC) Tetramer Market Drivers
        1.6.2 Major Histocompatibility Complex (MHC) Tetramer Market Restraints
        1.6.3 Major Histocompatibility Complex (MHC) Tetramer Industry Trends
        1.6.4 Major Histocompatibility Complex (MHC) Tetramer Industry Policy
2 Global Leading Players and Market Share
    2.1 By Revenue of Major Histocompatibility Complex (MHC) Tetramer, Global Market Share by Company, 2021-2026
    2.2 Global Major Histocompatibility Complex (MHC) Tetramer Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    2.3 Global Major Histocompatibility Complex (MHC) Tetramer Concentration Ratio
    2.4 Global Major Histocompatibility Complex (MHC) Tetramer Mergers & Acquisitions, Expansion Plans
    2.5 Global Major Histocompatibility Complex (MHC) Tetramer Major Companies Product Type
    2.6 Head Office and Area Served of Key Players
3 Japan Leading Players, Market Share and Ranking
    3.1 By Revenue of Major Histocompatibility Complex (MHC) Tetramer, Japan Market Share by Company, 2021-2026
    3.2 Japan Major Histocompatibility Complex (MHC) Tetramer Major Histocompatibility Complex (MHC) Tetramer Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
    4.1 Major Histocompatibility Complex (MHC) Tetramer Industry Chain
    4.2 Major Histocompatibility Complex (MHC) Tetramer Upstream Analysis
        4.2.1 Major Histocompatibility Complex (MHC) Tetramer Core Raw Materials
        4.2.2 Main Manufacturers of Major Histocompatibility Complex (MHC) Tetramer Core Raw Materials
    4.3 Midstream Analysis
    4.4 Downstream Analysis
    4.5 Major Histocompatibility Complex (MHC) Tetramer Production Mode
    4.6 Major Histocompatibility Complex (MHC) Tetramer Procurement Model
    4.7 Major Histocompatibility Complex (MHC) Tetramer Industry Sales Model and Sales Channels
        4.7.1 Major Histocompatibility Complex (MHC) Tetramer Sales Model
        4.7.2 Major Histocompatibility Complex (MHC) Tetramer Typical Distributors
5 Sights by Type
    5.1 Major Histocompatibility Complex (MHC) Tetramer Classification by Type
        5.1.1 MHC-I
        5.1.2 MHC-II
    5.2 by Type, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value & CAGR, 2021 VS 2025 VS 2032
    5.3 by Type, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2021-2032
6 Sights by Application
    6.1 Major Histocompatibility Complex (MHC) Tetramer Segment by Application
        6.1.1 Cancer research
        6.1.2 Virus research
        6.1.3 Bacteria research
        6.1.4 Other
    6.2 by Application, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value & CAGR, 2021 VS 2025 VS 2032
    6.3 by Application, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2021-2032
7 Sales Sights by Region
    7.1 By Region, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2021 VS 2025 VS 2032
    7.2 By Region, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2021-2032
    7.3 North America
        7.3.1 North America Major Histocompatibility Complex (MHC) Tetramer Market Size & Forecasts, 2021-2032
        7.3.2 By Country, North America Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share
    7.4 Europe
        7.4.1 Europe Major Histocompatibility Complex (MHC) Tetramer Market Size & Forecasts, 2021-2032
        7.4.2 By Country, Europe Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share
    7.5 Asia Pacific
        7.5.1 Asia Pacific Major Histocompatibility Complex (MHC) Tetramer Market Size & Forecasts, 2021-2032
        7.5.2 By Country/Region, Asia Pacific Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share
    7.6 South America
        7.6.1 South AmericaMajor Histocompatibility Complex (MHC) Tetramer Market Size & Forecasts, 2021-2032
        7.6.2 By Country, South America Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share
    7.7 Middle East & Africa
8 Sales Sights by Country Level
    8.1 By Country, Global Major Histocompatibility Complex (MHC) Tetramer Market Size & CAGR, 2021 VS 2025 VS 2032
    8.2 By Country, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2021-2032
    8.3 United States
        8.3.1 United States Major Histocompatibility Complex (MHC) Tetramer Market Size, 2021-2032
        8.3.2 by Type, United States Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
        8.3.3 by Application, United States Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
    8.4 Europe
        8.4.1 Europe Major Histocompatibility Complex (MHC) Tetramer Market Size, 2021-2032
        8.4.2 by Type, Europe Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
        8.4.3 by Application, Europe Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
    8.5 China
        8.5.1 China Major Histocompatibility Complex (MHC) Tetramer Market Size, 2021-2032
        8.5.2 by Type, China Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
        8.5.3 by Application, China Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
    8.6 Japan
        8.6.1 Japan Major Histocompatibility Complex (MHC) Tetramer Market Size, 2021-2032
        8.6.2 by Type, Japan Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
        8.6.3 by Application, Japan Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
    8.7 South Korea
        8.7.1 South Korea Major Histocompatibility Complex (MHC) Tetramer Market Size, 2021-2032
        8.7.2 by Type, South Korea Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
        8.7.3 by Application, South Korea Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
    8.8 Southeast Asia
        8.8.1 Southeast Asia Major Histocompatibility Complex (MHC) Tetramer Market Size, 2021-2032
        8.8.2 by Type, Southeast Asia Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
        8.8.3 by Application, Southeast Asia Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
    8.9 India
        8.9.1 India Major Histocompatibility Complex (MHC) Tetramer Market Size, 2021-2032
        8.9.2 by Type, India Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
        8.9.3 by Application, India Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
    8.10 Middle East & Africa
        8.10.1 Middle East & Africa Major Histocompatibility Complex (MHC) Tetramer Market Size, 2021-2032
        8.10.2 by Type, Middle East & Africa Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
        8.10.3 by Application, Middle East & Africa Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
9 Company Profile
    9.1 MBL Life Science
        9.1.1 MBL Life Science Company Information, Head Office, Market Area, and Industry Position
        9.1.2 MBL Life Science Company Profile and Main Business
        9.1.3 MBL Life Science Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
        9.1.4 MBL Life Science Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, 2021-2026
        9.1.5 MBL Life Science Recent Developments
    9.2 ProImmune
        9.2.1 ProImmune Company Information, Head Office, Market Area, and Industry Position
        9.2.2 ProImmune Company Profile and Main Business
        9.2.3 ProImmune Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
        9.2.4 ProImmune Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, 2021-2026
        9.2.5 ProImmune Recent Developments
    9.3 BioLegend
        9.3.1 BioLegend Company Information, Head Office, Market Area, and Industry Position
        9.3.2 BioLegend Company Profile and Main Business
        9.3.3 BioLegend Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
        9.3.4 BioLegend Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, 2021-2026
        9.3.5 BioLegend Recent Developments
    9.4 KACTUS
        9.4.1 KACTUS Company Information, Head Office, Market Area, and Industry Position
        9.4.2 KACTUS Company Profile and Main Business
        9.4.3 KACTUS Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
        9.4.4 KACTUS Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, 2021-2026
        9.4.5 KACTUS Recent Developments
    9.5 Creative Biolabs
        9.5.1 Creative Biolabs Company Information, Head Office, Market Area, and Industry Position
        9.5.2 Creative Biolabs Company Profile and Main Business
        9.5.3 Creative Biolabs Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
        9.5.4 Creative Biolabs Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, 2021-2026
        9.5.5 Creative Biolabs Recent Developments
    9.6 immunAware
        9.6.1 immunAware Company Information, Head Office, Market Area, and Industry Position
        9.6.2 immunAware Company Profile and Main Business
        9.6.3 immunAware Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
        9.6.4 immunAware Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, 2021-2026
        9.6.5 immunAware Recent Developments
    9.7 HELIXGEN
        9.7.1 HELIXGEN Company Information, Head Office, Market Area, and Industry Position
        9.7.2 HELIXGEN Company Profile and Main Business
        9.7.3 HELIXGEN Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
        9.7.4 HELIXGEN Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, 2021-2026
        9.7.5 HELIXGEN Recent Developments
    9.8 ACROBiosystems
        9.8.1 ACROBiosystems Company Information, Head Office, Market Area, and Industry Position
        9.8.2 ACROBiosystems Company Profile and Main Business
        9.8.3 ACROBiosystems Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
        9.8.4 ACROBiosystems Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, 2021-2026
        9.8.5 ACROBiosystems Recent Developments
10 Conclusion
11 Appendix
    11.1 Research Methodology
    11.2 Data Source
        11.2.1 Secondary Sources
        11.2.2 Primary Sources
    11.3 Market Estimation Model
    11.4 Disclaimer
title

Table of Figures

List of Tables
 Table 1. Major Histocompatibility Complex (MHC) Tetramer Consumption Value & CAGR: Japan VS Global, 2021-2032, US$ Million
 Table 2. Major Histocompatibility Complex (MHC) Tetramer Market Restraints
 Table 3. Major Histocompatibility Complex (MHC) Tetramer Market Trends
 Table 4. Major Histocompatibility Complex (MHC) Tetramer Industry Policy
 Table 5. Global Major Histocompatibility Complex (MHC) Tetramer Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
 Table 6. Global Major Histocompatibility Complex (MHC) Tetramer Revenue Share by Company, 2021-2026, Ranked by Data of 2025
 Table 7. Global Major Histocompatibility Complex (MHC) Tetramer Manufacturers Market Concentration Ratio (CR3 and HHI)
 Table 8. Global Major Histocompatibility Complex (MHC) Tetramer Mergers & Acquisitions, Expansion Plans
 Table 9. Global Major Histocompatibility Complex (MHC) Tetramer Major Companies Product Type
 Table 10. Head Office and Area Served of Key Players
 Table 11. Japan Major Histocompatibility Complex (MHC) Tetramer Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
 Table 12. Japan Major Histocompatibility Complex (MHC) Tetramer Revenue Market Share by Company, 2021-2026
 Table 13. Global Key Players of Major Histocompatibility Complex (MHC) Tetramer Upstream (Raw Materials)
 Table 14. Global Major Histocompatibility Complex (MHC) Tetramer Typical Customers
 Table 15. Major Histocompatibility Complex (MHC) Tetramer Typical Distributors
 Table 16. by Type, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 17. by Application, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 18. By Region, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2021 VS 2025 VS 2032, US$ Million
 Table 19. By Region, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2021-2032, US$ Million
 Table 20. By Country, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 21. By Country, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2021-2032, US$ Million
 Table 22. By Country, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2021-2032
 Table 23. MBL Life Science Company Information, Head Office, Market Area, and Industry Position
 Table 24. MBL Life Science Company Profile and Main Business
 Table 25. MBL Life Science Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
 Table 26. MBL Life Science Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, US$ Million, 2021-2026
 Table 27. MBL Life Science Recent Developments
 Table 28. ProImmune Company Information, Head Office, Market Area, and Industry Position
 Table 29. ProImmune Company Profile and Main Business
 Table 30. ProImmune Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
 Table 31. ProImmune Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, US$ Million, 2021-2026
 Table 32. ProImmune Recent Developments
 Table 33. BioLegend Company Information, Head Office, Market Area, and Industry Position
 Table 34. BioLegend Company Profile and Main Business
 Table 35. BioLegend Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
 Table 36. BioLegend Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, US$ Million, 2021-2026
 Table 37. BioLegend Recent Developments
 Table 38. KACTUS Company Information, Head Office, Market Area, and Industry Position
 Table 39. KACTUS Company Profile and Main Business
 Table 40. KACTUS Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
 Table 41. KACTUS Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, US$ Million, 2021-2026
 Table 42. KACTUS Recent Developments
 Table 43. Creative Biolabs Company Information, Head Office, Market Area, and Industry Position
 Table 44. Creative Biolabs Company Profile and Main Business
 Table 45. Creative Biolabs Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
 Table 46. Creative Biolabs Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, US$ Million, 2021-2026
 Table 47. Creative Biolabs Recent Developments
 Table 48. immunAware Company Information, Head Office, Market Area, and Industry Position
 Table 49. immunAware Company Profile and Main Business
 Table 50. immunAware Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
 Table 51. immunAware Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, US$ Million, 2021-2026
 Table 52. immunAware Recent Developments
 Table 53. HELIXGEN Company Information, Head Office, Market Area, and Industry Position
 Table 54. HELIXGEN Company Profile and Main Business
 Table 55. HELIXGEN Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
 Table 56. HELIXGEN Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, US$ Million, 2021-2026
 Table 57. HELIXGEN Recent Developments
 Table 58. ACROBiosystems Company Information, Head Office, Market Area, and Industry Position
 Table 59. ACROBiosystems Company Profile and Main Business
 Table 60. ACROBiosystems Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
 Table 61. ACROBiosystems Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, US$ Million, 2021-2026
 Table 62. ACROBiosystems Recent Developments


List of Figures
 Figure 1. Major Histocompatibility Complex (MHC) Tetramer Picture
 Figure 2. Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value, (US$ million) & (2021-2032)
 Figure 3. Japan Major Histocompatibility Complex (MHC) Tetramer Consumption Value, (US$ million) & (2021-2032)
 Figure 4. By Consumption Value, Japan Major Histocompatibility Complex (MHC) Tetramer Market Share of Global, 2021-2032
 Figure 5. Global Major Histocompatibility Complex (MHC) Tetramer Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2025
 Figure 6. Japan Major Histocompatibility Complex (MHC) Tetramer Key Participants, Market Share, 2025
 Figure 7. Major Histocompatibility Complex (MHC) Tetramer Industry Chain
 Figure 8. Major Histocompatibility Complex (MHC) Tetramer Procurement Model
 Figure 9. Major Histocompatibility Complex (MHC) Tetramer Sales Model
 Figure 10. Major Histocompatibility Complex (MHC) Tetramer Sales Channels, Direct Sales, and Distribution
 Figure 11. MHC-I
 Figure 12. MHC-II
 Figure 13. by Type, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2021-2032, US$ Million
 Figure 14. by Type, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2021-2032
 Figure 15. Cancer research
 Figure 16. Virus research
 Figure 17. Bacteria research
 Figure 18. Other
 Figure 19. by Application, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2021-2032, US$ Million
 Figure 20. by Application, Global Major Histocompatibility Complex (MHC) Tetramer Revenue Market Share, 2021-2032
 Figure 21. By Region, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2021-2032
 Figure 22. North America Major Histocompatibility Complex (MHC) Tetramer Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 23. By Country, North America Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025
 Figure 24. Europe Major Histocompatibility Complex (MHC) Tetramer Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 25. By Country, Europe Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025
 Figure 26. Asia Pacific Major Histocompatibility Complex (MHC) Tetramer Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 27. By Country/Region, Asia Pacific Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025
 Figure 28. South America Major Histocompatibility Complex (MHC) Tetramer Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 29. By Country, South America Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025
 Figure 30. Middle East & Africa Major Histocompatibility Complex (MHC) Tetramer Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 31. United States Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2021-2032, US$ Million
 Figure 32. by Type, United States Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
 Figure 33. by Application, United States Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
 Figure 34. Europe Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2021-2032, US$ Million
 Figure 35. by Type, Europe Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
 Figure 36. by Application, Europe Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
 Figure 37. China Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2021-2032, US$ Million
 Figure 38. by Type, China Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
 Figure 39. by Application, China Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
 Figure 40. Japan Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2021-2032, US$ Million
 Figure 41. by Type, Japan Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
 Figure 42. by Application, Japan Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
 Figure 43. South Korea Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2021-2032, US$ Million
 Figure 44. by Type, South Korea Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
 Figure 45. by Application, South Korea Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
 Figure 46. Southeast Asia Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2021-2032, US$ Million
 Figure 47. by Type, Southeast Asia Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
 Figure 48. by Application, Southeast Asia Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
 Figure 49. India Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2021-2032, US$ Million
 Figure 50. by Type, India Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
 Figure 51. by Application, India Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
 Figure 52. Middle East & Africa Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2021-2032, US$ Million
 Figure 53. by Type, Middle East & Africa Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
 Figure 54. by Application, Middle East & Africa Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2025 VS 2032
 Figure 55. Research Methodology
 Figure 56. Breakdown of Primary Interviews
 Figure 57. Bottom-up Approaches
 Figure 58. Top-down Approaches

お見積>

サンプルお申込み>

今すぐ購入>

PDFダウンロード>

当社から購入のメリット
  • jiantou

    多言語（英語、日本語）のサンプル提供

  • jiantou

    プロフェッショナルな日本語翻訳を提供

  • jiantou

    請求書、クレジットカードでのお支払いが可能です

  • jiantou

    必要なチャプターやカスタマイズされたレポートの注文が可能

  • jiantou

    購入後、アナリストに直接連絡することができます

購入方法
shunxu

  • 必要な言語とバージョンのレポート選択

  • レポート要件と見積もり依頼

  • 電子メールによる注文

  • レポートの入手（英語版は2～4営業日、日本語版は8～10営業日）

  • クレジットカード決済、オフライン振込に対応（後払い可）

※当サイトに掲載されていない海外調査報告書も当社経由でご購入いただけますので、お問い合わせください。

※市場調査レポートの購入や市場調査をご希望の場合は、実績と信頼のある株式会社市場調査センターにお任せください。

*フォーチュン500企業は当社と緊密な協力関係を確立しています

クライアント様（例）
ご利用ガイド
利用規約よくあるご質問プライバシーポリシー支払い方法と購入ガイド
お電話でのお問い合わせ
email050-5840-2692 日本
email0081-50-5840-2692 グローバル
9:00-18:00 (土日・祝日を除く)
底部logo
Copyright 2016-2026 Global Reports著作権所有